Mabanal, Jerald S.
HRN: 24-88-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/22/2024
CEFTRIAXONE 1G (VIAL)
04/22/2024
04/28/2024
IV DRIP
4grams
Q24
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes